PCV72 Cost-Effectiveness of Rivaroxaban Versus Acenocumarol in the Stroke Prevention in Patients With Non-Valvular Atrial Fibrilation in the Spanish Setting
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.1015
https://www.valueinhealthjournal.com/article/S1098-3015(12)02728-3/fulltext
Section Title :
Cardiovascular Disorders
Section Order :
521
First Page :
A375
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02728-3&doi=10.1016/j.jval.2012.08.1015